ADVERTISEMENT
Manila Bulletin devider Lifestyle devider Usana unveils latest skin serum

Usana unveils latest skin serum

Celavive Resurfacing Serum is made to help promote healthy aging

Published Jan 15, 2025 09:58 am

Our skin’s increasing exposure to UV rays and air pollutants can cause a wide range of skin concerns including dehydration, discoloration, and premature aging. While there are a lot of quick fixes available in the market, finding skincare products that will give you that radiant-looking skin you’ve always wanted is always the best way to go. The good news is that’s exactly what Usana’s newest product promises. 

Internationally recognized as a company that produces science-backed health and wellness products, Usana introduces the Celavive Resurfacing Serum — a 4-in-1 serum with ingredients to help promote healthy aging including the four main skin concerns: texture, tone, clarity, and firmness.

Usana Celevive
Usana Celavive Resurfacing Serum

New year, new glow

The launch of the its Celavive Resurfacing Serum encourages everyone to take on the journey toward 365 days of glowing skin as its cutting-edge, science-based formula covers the skin with AHAs, BHAs, mandelic acid, and bakuchiol which is clinically tested to deliver immediate, visible results. Continuous could lessen the appearance of dark spots, breakouts, visible redness, and reduce fine lines and wrinkles. 

During its launch, Usana PH general manager, Cherry Ampig, reiterates one of the brand’s values, “We are proud to be part of a company that takes a full-science approach to product creation. This ensures that every product that USANA produces is meant to deliver its promised results to its end-user. And today, we confidently say that after just one use, you will see how the Celavive Resurfacing Serum will transform your skin,” she said.

Usana serum launch
From left: Joyce Ramallosa, senior market development and marketing manager, Usana Philippines, Francis J. Kong, and Tessa Prieto, brand ambassadors, Cherry Ampig, country manager, Usana Philippines, and Leeo Kim, marketing supervisor, Usana  Philippines

In demand luxury skincare

Even before its grand launch which is set on January 26, 2025, the Celavive Resurfacing Serum has already been sold out during its two online pre-selling days last December 2024 and is getting its waitlist filled, proving the product’s efficacy and outstanding results.

In USANA’s exclusive product launch, two of its renowned brand ambassadors, Francis J. Kong and Tessa Prieto, shared their amazement in how the serum worked wonders for them. “We heard that the product was sold out in just two days and I must say we’re lucky to be one of the  few who were given the opportunity to try it first. I honestly thought my skin was doing fine but after I tried the Celavive Resurfacing Serum, that’s when I saw that it could be better,” Kong shared.

The Celavive Resurfacing Serum will be made available in January 2025. Make sure  to check Usana’s official Facebook and Instagram pages for updates or ask an authorized associate.

Related Tags

USANA
ADVERTISEMENT
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1561_widget.title }}

{{ item.title }}
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1562_widget.title }}

{{ item.title }}
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1563_widget.title }}

{{ item.title }}

{{ articles_filter_1564_widget.title }}

{{ item.title }}
.mb-article-details { position: relative; } .mb-article-details .article-body-preview, .mb-article-details .article-body-summary{ font-size: 17px; line-height: 30px; font-family: "Libre Caslon Text", serif; color: #000; } .mb-article-details .article-body-preview iframe , .mb-article-details .article-body-summary iframe{ width: 100%; margin: auto; } .read-more-background { background: linear-gradient(180deg, color(display-p3 1.000 1.000 1.000 / 0) 13.75%, color(display-p3 1.000 1.000 1.000 / 0.8) 30.79%, color(display-p3 1.000 1.000 1.000) 72.5%); position: absolute; height: 200px; width: 100%; bottom: 0; display: flex; justify-content: center; align-items: center; padding: 0; } .read-more-background a{ color: #000; } .read-more-btn { padding: 17px 45px; font-family: Inter; font-weight: 700; font-size: 18px; line-height: 16px; text-align: center; vertical-align: middle; border: 1px solid black; background-color: white; } .hidden { display: none; }
function initializeAllSwipers() { // Get all hidden inputs with cms_article_id document.querySelectorAll('[id^="cms_article_id_"]').forEach(function (input) { const cmsArticleId = input.value; const articleSelector = '#article-' + cmsArticleId + ' .body_images'; const swiperElement = document.querySelector(articleSelector); if (swiperElement && !swiperElement.classList.contains('swiper-initialized')) { new Swiper(articleSelector, { loop: true, pagination: false, navigation: { nextEl: '#article-' + cmsArticleId + ' .swiper-button-next', prevEl: '#article-' + cmsArticleId + ' .swiper-button-prev', }, }); } }); } setTimeout(initializeAllSwipers, 3000); const intersectionObserver = new IntersectionObserver( (entries) => { entries.forEach((entry) => { if (entry.isIntersecting) { const newUrl = entry.target.getAttribute("data-url"); if (newUrl) { history.pushState(null, null, newUrl); let article = entry.target; // Extract metadata const author = article.querySelector('.author-section').textContent.replace('By', '').trim(); const section = article.querySelector('.section-info ').textContent.replace(' ', ' '); const title = article.querySelector('.article-title h1').textContent; // Parse URL for Chartbeat path format const parsedUrl = new URL(newUrl, window.location.origin); const cleanUrl = parsedUrl.host + parsedUrl.pathname; // Update Chartbeat configuration if (typeof window._sf_async_config !== 'undefined') { window._sf_async_config.path = cleanUrl; window._sf_async_config.sections = section; window._sf_async_config.authors = author; } // Track virtual page view with Chartbeat if (typeof pSUPERFLY !== 'undefined' && typeof pSUPERFLY.virtualPage === 'function') { try { pSUPERFLY.virtualPage({ path: cleanUrl, title: title, sections: section, authors: author }); } catch (error) { console.error('ping error', error); } } // Optional: Update document title if (title && title !== document.title) { document.title = title; } } } }); }, { threshold: 0.1 } ); function showArticleBody(button) { const article = button.closest("article"); const summary = article.querySelector(".article-body-summary"); const body = article.querySelector(".article-body-preview"); const readMoreSection = article.querySelector(".read-more-background"); // Hide summary and read-more section summary.style.display = "none"; readMoreSection.style.display = "none"; // Show the full article body body.classList.remove("hidden"); } document.addEventListener("DOMContentLoaded", () => { let loadCount = 0; // Track how many times articles are loaded const offset = [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]; // Offset values const currentUrl = window.location.pathname.substring(1); let isLoading = false; // Prevent multiple calls if (!currentUrl) { console.log("Current URL is invalid."); return; } const sentinel = document.getElementById("load-more-sentinel"); if (!sentinel) { console.log("Sentinel element not found."); return; } function isSentinelVisible() { const rect = sentinel.getBoundingClientRect(); return ( rect.top < window.innerHeight && rect.bottom >= 0 ); } function onScroll() { if (isLoading) return; if (isSentinelVisible()) { if (loadCount >= offset.length) { console.log("Maximum load attempts reached."); window.removeEventListener("scroll", onScroll); return; } isLoading = true; const currentOffset = offset[loadCount]; window.loadMoreItems().then(() => { let article = document.querySelector('#widget_1690 > div:nth-last-of-type(2) article'); intersectionObserver.observe(article) loadCount++; }).catch(error => { console.error("Error loading more items:", error); }).finally(() => { isLoading = false; }); } } window.addEventListener("scroll", onScroll); });
Join Our Newsletters

Sign up by email to receive news.

© 2025 Manila Bulletin The Nation's Leading Newspaper. All Rights Reserved.